Health

FDA to require vision loss warning on GLP-1 drug labels

Global News 10 Nov

Canada

FDA to require vision loss warning on GLP-1 drug labels — Sources: Global News

The labelling requirement stems from the findings of a 2024 study and subsequent FDA trials that tested the results of that study.

See all — Global News →

Aggregated from the leading newsrooms of the country. Every story links to its original source.

Health

The U.S. is now urging middle-aged men to routinely screen for prostate cancer. What about Canada?

Mice, pigeon infestations at Halifax-area hospitals lead to soaring pest-control costs

Severe stomach bug hits Montreal’s homeless population, shelter workers raise alarm

Ontario cancer patient calls for action on lab delays and technologist shortages

CTV News · 16 h

Study suggests not all obesity means ill-health

CTV News · 18 h

U.S. faces loss of measles-free status as experts meet for review

CTV News · 19 h

Adults think kids are more creative than they are, but new research shows that’s not the case

CTV News · 22 h

Various beers under Molson Coors banner recalled Canada-wide